Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

DWS Health Care Typ O

+ Add to Watchlist

DWSPHAK:GR

240.86 EUR 0.06 0.02%

As of 01:59:30 ET on 05/22/2015.

Snapshot for DWS Health Care Typ O (DWSPHAK)

Year To Date: +21.27% 3-Month: +8.89% 3-Year: +33.78% 52-Week Range: 156.52 - 249.65
1-Month: -2.19% 1-Year: +55.82% 5-Year: +23.67% Beta vs MSGUHC: 1.00

Mutual Fund Chart for DWSPHAK

No chart data available.
  • DWSPHAK:GR 240.86
  • 1M
  • 1Y
Interactive DWSPHAK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DWSPHAK

DWS Health Care Typ O is an open-end investment fund incorporated in Germany and Austria. The Fund's objective is income and growth. DWS Health Care Typ O invests in global pharmaceutical stocks with emphasis on large, multinational pharmaceutical companies, as well as innovative biotechnology stocks.

Inception Date: 11-10-1997 Telephone: Tel. 49-1803-10111011
Managers: THOMAS E BUCHER / HOLGER GEISSLER
Web Site: www.dws.de

Fundamentals for DWSPHAK

NAV (on 2015-05-22) 240.86
Assets (M) (on 2015-05-22) 377.63
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment -

Dividends for DWSPHAK

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for DWSPHAK

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.70
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.71

Top Fund Holdings for DWSPHAK

Filing Date: 03/31/2015
Name Position Value % of Total
Roche Holding AG 57,002 14,728,917 4.037%
Johnson & Johnson 155,010 14,634,733 4.011%
Pfizer Inc 442,300 14,392,298 3.945%
Gilead Sciences Inc 150,300 14,069,883 3.856%
Express Scripts Holding Co 177,076 14,060,092 3.854%
Biogen Inc 27,450 11,015,116 3.019%
Amgen Inc 70,150 10,715,776 2.937%
Celgene Corp 88,650 9,891,850 2.711%
AstraZeneca PLC 151,000 9,657,644 2.647%
GlaxoSmithKline PLC 451,000 9,655,760 2.646%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil